• Home
  • NEW DAY MEDICINE
  • 2 (88) 2026
  • 105 -2 (88) 2026 - Kayumova D.T., Yunusaliyeva D.A. - OPTIMIZATION OF ABORTION TREATMENT IN PATIENTS WITH ACQUIRED THROMBOPHILIA

105 -2 (88) 2026 - Kayumova D.T., Yunusaliyeva D.A. - OPTIMIZATION OF ABORTION TREATMENT IN PATIENTS WITH ACQUIRED THROMBOPHILIA

OPTIMIZATION OF ABORTION TREATMENT IN PATIENTS WITH ACQUIRED THROMBOPHILIA

Kayumova D.T. - Tashkent State Medical University

Yunusaliyeva D.A. - Tashkent State Medical University

Resume

Background. Recurrent miscarriage, defined as the occurrence of three or more consecutive pregnancy losses, affects 2–3% of women of reproductive age. While isolated early pregnancy loss is relatively frequent, recurrent miscarriage represents a distinct and complex clinical entity requiring tailored diagnostic and therapeutic approaches. Materials and Methods. This review synthesizes evidence from peer-reviewed studies and international clinical guidelines published between 2020 and 2025. Results. In patients diagnosed with antiphospholipid syndrome, combined therapy using anticoagulants and low-dose aspirin proved significantly more effective than aspirin monotherapy, resulting in a 50–60% improvement in pregnancy outcomes. Conclusion. Optimal management of recurrent miscarriage requires an individualized, multimodal treatment strategy integrating surgical correction, hormonal support, and immunologically targeted therapies.

Key words. Spontaneous miscarriage, thrombophilia, APS syndrome, anticoagulants, expectant management, drug therapy, surgical intervention.

First page

554

Last page

558

For citation:Kayumova D.T., Yunusaliyeva D.A. - OPTIMIZATION OF ABORTION TREATMENT IN PATIENTS WITH ACQUIRED THROMBOPHILIA//New Day in Medicine 2(88)2026 554-558 https://newdayworldmedicine.com/en/new_day_medicine/2-88-2026

List of References

  1. Ali S, Majid S, Ali MN, Taing S, El-Serehy Ha, et al. Evaluation of etiology and pregnancy outcome in recurrent miscarriage patients. Saudi J Biol Sci. 2020;27:2809–17.
  2. Beaman J, Prifti C, Schwarz EB, Sobota M. Medication to manage abortion and miscarriage. J Gen Intern Med. 2020;35:2398–405.
  3. Chen J, Yue J, Lu Y, Li T, Li X, Zhang JY. Recurrent miscarriage and low-titer antiphospholipid antibodies. Clin Rheumatol. 2024;43:1327–34.
  4. Chen Y, Xu W, Huang S, Li J, Li T, et al. Analysis of pregnancy outcomes in patients exhibiting recurrent miscarriage with concurrent low‐titer antiphospholipid antibodies. Am J Reprod Immunol. 2024;92:13940.
  5. Dimakou DB, Tamblyn J, Justin C, Coomarasamy A, Richter A. Diagnosis and management of idiopathic recurrent pregnancy loss (RPL): current immune testing and immunomodulatory treatment practice in the United Kingdom. J Reprod Immunol. 2022;153:103662.
  6. Di Simone N, Santamaria Ortiz A, Specchia M, Tersigni C, Villa P, et al. Recent insights on the maternal microbiota: impact on pregnancy outcomes. Front Immunol. 2020;11:528202.
  7. Gozzoli GI, Piovani E, Negri B, Mascherpa M, Orabona R, et al. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: a single-center prospective study on 151 pregnancies. Front Immunol. 2022;13:953043.
  8. Haddock L, Gordon S, Lewis SE, Larsen P, Shehata A. Sperm DNA fragmentation is a novel biomarker for EPL. Reprod Biomed Online. 2021;42:175–84.
  9. Lee EE, Jun JK, Lee EB. Management of women with antiphospholipid antibodies or antiphospholipid syndrome during pregnancy. J Korean Med Sci. 2021;36.
  10. Mahmood T, Ullah Z, Latif A, Sultan BA, Zubair M, et al. Computer-aided diagnosis in spontaneous abortion: a histopathology dataset and benchmark for products of conception. Diagnostics. 2024;14:2877.
  11. Srivastava P, Bamba C, Chopra S, Rohilla M, Chaudhry C, et al. Identification of genetic alterations in couples and their products of conceptions from recurrent pregnancy loss in North Indian population. Front Genet. 2023;14:1155211.
  12. Strumpf E, Lang A, Austin N, Derksen SA, Bolton JM, et al. Prevalence and clinical, social, and health care predictors of miscarriage. BMC Pregnancy Childbirth. 2021;21:1–9.
  13. Tal E, Paul R, Dorsey M, Madden T. Comparison of EPL management between states with restrictive and supportive abortion policies. Womens Health Issues. 2023;33:126–32.

    file

    download